Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: improved long-term survival

被引：1
|
作者：
Tubben, Alwin [1 ,2 ]
Nienhuis, Hans L. A. [2 ,3 ]
van der Meer, Peter [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Dept Cardiol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Amyloidosis Ctr Expertise, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1002/ejhf.3053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2065 / 2066
页数：2
相关论文
共 50 条
  • [1] Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms
    Elliott, Perry
    Gundapaneni, Balarama
    Sultan, Marla B.
    Ines, Monica
    Garcia-Pavia, Pablo
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (11) : 2060 - 2064
  • [2] Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    CIRCULATION-HEART FAILURE, 2022, 15 (01) : E008193
  • [3] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142
  • [4] Long-term Survival Benefit of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
    Patel, Jignesh
    Elliott, Perry
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla
    Grogan, Martha
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S64 - S65
  • [5] Effects of tafamidis on heart failure hospitalization: the tale of the dog that did not bark. Letter regarding the article 'Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms'
    Aimo, Alberto
    Vergaro, Giuseppe
    Emdin, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 526 - 526
  • [6] Letter by Baldovino et al Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"
    Baldovino, Simone
    Costanzo, Piera
    Roccatello, Dario
    CIRCULATION-HEART FAILURE, 2022, 15 (07)
  • [7] Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
    Ghoneem, Ahmed
    Bhatti, Ammar W.
    Khadke, Sumanth
    Mitchell, Joshua
    Liu, Jennifer
    Zhang, Kathleen
    Trachtenberg, Barry
    Wechalekar, Ashutosh
    Cheng, Richard K.
    Baron, Suzanne J.
    Nohria, Anju
    Lenihan, Daniel
    Ganatra, Sarju
    Dani, Sourbha S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (06)
  • [8] Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
    Ghoneem, Ahmed
    Bhatti, Ammar W.
    Mitchell, Joshua D.
    Liu, Jennifer
    Zhang, Kathleen
    Trachtenberg, Barry
    Wechalekar, Ashtoush
    Cheng, Richard
    Baron, Suzanne J.
    Nohria, Anju
    Lenihan, Daniel
    Dani, Sourbha
    Ganatra, Sarju
    CIRCULATION, 2022, 146
  • [9] Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"
    Elliott, Perry
    Gundapaneni, Balarama
    Sultan, Marla B.
    CIRCULATION-HEART FAILURE, 2022, 15 (07)
  • [10] Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    FUTURE CARDIOLOGY, 2023, 19 (01) : 7 - 17
12345